|4Jan 8, 4:17 PM ET

ELITE PHARMACEUTICALS INC /NV/ 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jan 8, 2016

Insider Transaction Report

Form 4
Period: 2015-10-30
Hakim Nasrat A
DirectorPresident & CEO
Transactions
  • Other

    common

    2015-10-30+113,954113,954 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: By IRA)
    2,700,000
  • Common Stock

    19,072,514
Footnotes (4)
  • [F1]Milestone payment from company pursuant to a Strategic Alliance Agreement with Entity.
  • [F2]Shares eventually transferred from Entity in which Mikah Pharma LLC has a beneficial interest to Mikah Pharma LLC.
  • [F3]The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
  • [F4]The securities are held by Nasrat Hakim .

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT